Teva Chairman Frost Backs Management Amid Criticism From Goldman

Teva Pharmaceutical Industries Ltd. Chairman Phillip Frost said he backed the management’s strategy following criticism from Goldman Sachs Group Inc. and Morgan Stanley analysts who are advising investors to sell.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.